{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T11:12:22Z","timestamp":1782645142606,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA99908"],"award-info":[{"award-number":["R01CA99908"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA184101"],"award-info":[{"award-number":["R01CA184101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K12-HD063117"],"award-info":[{"award-number":["K12-HD063117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Cancer Society Institutional Research Grant"},{"name":"Department of Obstetrics and Gynecology Research Development Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ygyno.2015.10.023","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T20:42:32Z","timestamp":1446583352000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices"],"prefix":"10.1016","volume":"140","author":[{"given":"Henry D.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Devor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina W.","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan I.","family":"Samuelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica C.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Goodheart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly K.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.10.023_bb0005","series-title":"Cancer Facts and Figures 2015","year":"2015"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pathol.2.010506.091905","article-title":"Endometrial carcinoma","volume":"2","author":"Di Cristofano","year":"2007","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0030","first-page":"428","article-title":"Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate","volume":"41","author":"Cullins","year":"1996","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mob.2002.122130","article-title":"Intrauterine progesterone treatment of early endometrial cancer","volume":"186","author":"Montz","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0040","first-page":"718","article-title":"Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer","volume":"102","author":"Gotlieb","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0045","first-page":"119","article-title":"Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases","volume":"21","author":"Jobo","year":"2000","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature","volume":"79","author":"Kim","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0070","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9378(11)91709-8","article-title":"Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case\u2013control study","volume":"167","author":"Brinton","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.033","article-title":"Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy","volume":"132","author":"Gunderson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0080","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0085","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","article-title":"Prediction of regression and relapse of endometrial hyperplasia with conservative therapy","volume":"121","author":"Gallos","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0090","doi-asserted-by":"crossref","first-page":"479541","DOI":"10.1155\/2013\/479541","article-title":"The estrogen receptor joins other cancer biomarkers as a predictor of outcome","volume":"2013","author":"Leslie","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0095","first-page":"429","article-title":"Past, present, and future of hormonal therapy in recurrent endometrial cancer","volume":"6","author":"Carlson","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/PGP.0000000000000177","article-title":"Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"33","author":"Zaino","year":"2014","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"36","key":"10.1016\/j.ygyno.2015.10.023_bb0110","first-page":"e1","article-title":"Biomarkers of progestin therapy resistance and endometrial hyperplasia progression","volume":"207","author":"Upson","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ygyno.2014.01.015","article-title":"Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study","volume":"132","author":"Fleming","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-7-25","volume":"7","author":"Koo","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0125","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.18632\/oncotarget.2392","article-title":"Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer","volume":"5","author":"Yang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0135","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0140","series-title":"Statistical Methods","author":"Snedecor","year":"1989"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2007.03.042","article-title":"Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group study","volume":"106","author":"Singh","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2004.09.057","article-title":"Progesterone receptor isoform identification and subcellular localization in endometrial cancer","volume":"96","author":"Leslie","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"255","key":"10.1016\/j.ygyno.2015.10.023_bb0160","first-page":"e1","article-title":"Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma","volume":"210","author":"Kudesia","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0170","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2015.10.023_bb0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1078-0432.CCR-10-1287","article-title":"Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth","volume":"17","author":"Kyo","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.10.023_bb0180","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.7314\/APJCP.2014.15.8.3737","article-title":"Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia","volume":"15","author":"Mesci-Haftaci","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T22:52:09Z","timestamp":1537224729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0090825815301700"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.10.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}